Skip to main content

This job has expired

You will need to login before you can apply for a job.

Scientist, Biophysical Characterization, Analytical Development

Employer
Intellia Therapeutics
Location
Cambridge, MA
Start date
Feb 2, 2023

Job Details

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

How you will Achieve More with Intellia:

In this visible role you will leverage your skill and experience to:

  • Identify, evaluate, and execute biophysical methods to support characterization projects.
  • Work with our research and development partners to creatively exploit biophysical techniques to answer interesting questions and increase the understanding of our products.
  • Work with our CROs to transfer and troubleshoot biophysical methods.
  • Support regulatory submissions with high quality biophysical data.

About You:

Are you passionate about the characterization of biomolecules? Are you skilled in biophysical method development focused on the structure and function of oligonucleotides, LNPs, or AAVs? If you say yes, we encourage you to apply! Your qualifications and skills should include:

  • PhD with 0-3 years of biotech experience or a Master’s degree with more than 6 years.
  • Proficiency in biophysical techniques including AUC, CD, and light scattering is required.
  • Knowledge of RNA secondary structures and folding.
  • Organized, detail-oriented, and demonstrated independent thinker who continuously seeks innovative solutions.
  • Excellent verbal and written communication, teamwork, and strong problem-solving skills.

Meet your future team:

Biophysical characterization is a new function within the Analytical Development team. Like the entire Analytical Development team, we are a growing group of energetic, brilliant, fun, and motivated individuals. We add a new dimension to the work of all the other scientists in Analytical Development as well as with colleagues in process and formulation development and basic research. The entire team is focused on creating an environment where we all can grow as scientists and leaders in the biopharmaceutical industry.

You will report to the Principal Scientist who leads the biophysical characterization group within Analytical Development. She loves to see people grow and develop their skills. She looks forward to learning from your experiences and building the team with you.

Covid-19 Vaccination Policy: All Intellia employees, regardless of work location, must be fully vaccinated for COVID-19. This requirement includes a booster dose once eligible. Requests for exemption for medical or sincerely held religious beliefs will be considered.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert